Sertraline or placebo in chronic breathlessness? Lessons from placebo research
- PMID: 30655451
- DOI: 10.1183/13993003.02225-2018
Sertraline or placebo in chronic breathlessness? Lessons from placebo research
Conflict of interest statement
Conflict of interest: K. Pattinson reports personal fees for consultancy from Nektar Pharmaceuticals, outside the submitted work; and is supported by the National Institute for Health Research, Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford. Conflict of interest: V. Wanigasekera has nothing to disclose.
Comment in
-
Sertraline or placebo in chronic breathlessness? Lessons from placebo research.Eur Respir J. 2019 Jan 17;53(1):1802316. doi: 10.1183/13993003.02316-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30655452 No abstract available.
-
The importance of differentiating behavioural and psychological treatment effects from placebo in respiratory interventions.Eur Respir J. 2019 Apr 25;53(4):1900156. doi: 10.1183/13993003.00156-2019. Print 2019 Apr. Eur Respir J. 2019. PMID: 31023864 No abstract available.
Comment on
-
Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial.Eur Respir J. 2019 Jan 17;53(1):1801270. doi: 10.1183/13993003.01270-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30361250 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources